E Mantzou
Overview
Explore the profile of E Mantzou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Linz R, Puhlmann L, Apostolakou F, Mantzou E, Papassotiriou I, Chrousos G, et al.
Neuropsychopharmacology
. 2019 Apr;
44(10):1797-1804.
PMID: 30991416
Brain-derived neurotrophic factor (BDNF) is an essential facilitator of neuronal plasticity. By counteracting the adverse effects of excessive stress-induced glucocorticoid signaling, BDNF has been implicated as a resilience factor to...
2.
Hatzioannou A, Kanistras I, Mantzou E, Anastasiou E, Peppa M, Sarantopoulou V, et al.
Int J Endocrinol
. 2015 Aug;
2015:849615.
PMID: 26229534
Advanced glycation end products (AGEs) are formed on proteins after exposure to high concentrations of glucose and modify protein's immunogenicity. Herein, we investigated whether the modification of thyroglobulin (Tg) by...
3.
Pappa T, Vemmos K, Mantzou E, Savvari P, Stamatelopoulos K, Alevizaki M
Eur J Neurol
. 2012 Apr;
19(10):1300-4.
PMID: 22509950
Background: Data on the role of endogenous sex steroids in cerebrovascular disease are sparse. Estradiol is a hormone with diverse actions on the central nervous system. Our aim was to...
4.
Stergiou E, Diamanti E, Agakidis C, Sarafidis K, Mantzou E, Drossou V
J Clin Endocrinol Metab
. 2011 Dec;
97(2):E238-42.
PMID: 22162474
Context: Experimental studies linked gestational diabetes mellitus (GDM) and intrauterine growth restriction (IUGR) with altered expression of the offspring's hypothalamic galanin mRNA, possibly contributing to the development of obesity and...
5.
Tzanela M, Mantzou E, Saltiki K, Tampourlou M, Kalogeris N, Hadjidakis D, et al.
J Endocrinol Invest
. 2011 Jul;
35(4):395-400.
PMID: 21738001
Background: Adrenal incidentaloma (AI) is a common clinical problem. Subtle hormonal abnormalities are present in a substantial proportion of patients. BCL1 gene polymorphism of the glucocorticoid receptor (GR) is associated...
6.
Vergou T, Mantzou E, Tseke P, Moustou A, Katsambas A, Alevizaki M, et al.
J Eur Acad Dermatol Venereol
. 2011 Apr;
26(4):413-6.
PMID: 21521376
Background: During the last decades an increase has been observed regarding acne in adults and especially women. Objective: To evaluate the association between thyroid disorder and the presence of post-adolescent...
7.
Kaloumenou I, Duntas L, Alevizaki M, Mantzou E, Chiotis D, Mengreli C, et al.
Horm Metab Res
. 2010 Feb;
42(4):285-9.
PMID: 20119886
The aim of the work was to assess thyroid function in children and adolescents in an iodine replete area and to explore possible effects of age, gender, puberty, and adiposity....
8.
Saltiki K, Mantzou E, Doukas C, Kanakakis I, Zotos P, Lazaros L, et al.
Exp Clin Endocrinol Diabetes
. 2009 Nov;
117(10):610-5.
PMID: 19938352
Aim: Estrogen action is exerted on the vasculature through estrogen receptors ER alpha and ER beta. We have previously reported significant association of ER alpha gene (ESR1) variants with more...
9.
Psaltopoulou T, Ilias I, Toumanidis S, Mantzou E, Marafellia P, Piperingos G, et al.
Eur J Intern Med
. 2007 Aug;
18(5):423-9.
PMID: 17693232
Background: Subclinical hyperthyroidism (SH) is defined by suppressed TSH and normal levels of thyroid hormones. Endogenous subclinical hyperthyroidism (ESH) is probably less common than exogenous SH. Adverse effects of SH...
10.
Duntas L, Mantzou E, Koutras D
Thyroid
. 2001 Aug;
11(8):779-82.
PMID: 11525272
Long-term estrogen therapy can modify thyroid hormone kinetics by increasing serum concentration of thyroxine-binding globulin (TBG). Raloxifene is a recently developed selective estrogen receptor modulator (SERM) for the treatment of...